0001209191-20-031663.txt : 20200522 0001209191-20-031663.hdr.sgml : 20200522 20200522150019 ACCESSION NUMBER: 0001209191-20-031663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200520 FILED AS OF DATE: 20200522 DATE AS OF CHANGE: 20200522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hochman David P CENTRAL INDEX KEY: 0001292834 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37348 FILM NUMBER: 20905430 MAIL ADDRESS: STREET 1: 15 WESTON HILL RD. CITY: RIVERSIDE STATE: CT ZIP: 06878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corbus Pharmaceuticals Holdings, Inc. CENTRAL INDEX KEY: 0001595097 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464348039 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 RIVER RIDGE DRIVE CITY: NORWOOD STATE: MA ZIP: 02062 BUSINESS PHONE: 617-963-0103 MAIL ADDRESS: STREET 1: 500 RIVER RIDGE DRIVE CITY: NORWOOD STATE: MA ZIP: 02062 FORMER COMPANY: FORMER CONFORMED NAME: SAV Acquisition Corp DATE OF NAME CHANGE: 20131220 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-20 0 0001595097 Corbus Pharmaceuticals Holdings, Inc. CRBP 0001292834 Hochman David P C/O CORBUS PHARMACEUTICALS HOLDINGS, INC 500 RIVER RIDGE DRIVE NORWOOD MA 02062 1 0 0 0 Stock Option(right to buy) 7.30 2020-05-20 4 A 0 40500 0.00 A 2030-05-20 Common Stock 40500 40500 D The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant. /s/ David Hochman 2020-05-22